<!DOCTYPE article
PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD with MathML3 v1.3 20210610//EN" "JATS-archivearticle1-3-mathml3.dtd">
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" dtd-version="1.3" xml:lang="en" article-type="abstract"><?properties open_access?><processing-meta base-tagset="archiving" mathml-version="3.0" table-model="xhtml" tagset-family="jats"><restricted-by>pmc</restricted-by></processing-meta><front><journal-meta><journal-id journal-id-type="nlm-ta">Eur Psychiatry</journal-id><journal-id journal-id-type="iso-abbrev">Eur Psychiatry</journal-id><journal-id journal-id-type="publisher-id">EPA</journal-id><journal-title-group><journal-title>European Psychiatry</journal-title></journal-title-group><issn pub-type="ppub">0924-9338</issn><issn pub-type="epub">1778-3585</issn><publisher><publisher-name>Cambridge University Press</publisher-name><publisher-loc>Cambridge, UK</publisher-loc></publisher></journal-meta>
<article-meta><article-id pub-id-type="pmc">PMC11860624</article-id><article-id pub-id-type="doi">10.1192/j.eurpsy.2024.1459</article-id><article-id pub-id-type="other">EPV0843</article-id><article-id pub-id-type="pii">S0924933824014597</article-id><article-categories><subj-group subj-group-type="heading"><subject>Abstract</subject></subj-group><subj-group subj-group-type="section"><subject>e-Poster Viewing</subject></subj-group></article-categories><title-group><article-title>Non MRI Guided Accelerated Intermittent Theta Burst Stimulation is Effective in Patients with Treatment Resistant Depression and Suicidality</article-title></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><name><surname>Zayed</surname><given-names>A. E.</given-names></name><xref rid="aff3201" ref-type="aff"/><xref rid="cor1309" ref-type="corresp">
<sup>*</sup>
</xref></contrib><contrib contrib-type="author"><name><surname>Bassiony</surname><given-names>M. M.</given-names></name><xref rid="aff3201" ref-type="aff"/></contrib><contrib contrib-type="author"><name><surname>Youssef</surname><given-names>U. M.</given-names></name><xref rid="aff3201" ref-type="aff"/></contrib><contrib contrib-type="author"><name><surname>Salah Eldeen</surname><given-names>G. M.</given-names></name><xref rid="aff3201" ref-type="aff"/></contrib><contrib contrib-type="author"><name><surname>Elgohary</surname><given-names>H. M.</given-names></name><xref rid="aff3201" ref-type="aff"/></contrib><contrib contrib-type="author"><name><surname>Sehlo</surname><given-names>M. G.</given-names></name><xref rid="aff3201" ref-type="aff"/></contrib><contrib contrib-type="author"><name><surname>Hefny</surname><given-names>O. A.</given-names></name><xref rid="aff3201" ref-type="aff"/></contrib></contrib-group><aff id="aff3201">Psychiatry, <institution>Zagazig University</institution>, <city>Zagazig</city>, <country>Egypt</country></aff><author-notes><corresp id="cor1309"><label>*</label>Corresponding author.</corresp></author-notes><pub-date publication-format="electronic" date-type="collection" iso-8601-date="2024-04"><month>4</month><year>2024</year></pub-date><pub-date pub-type="epub"><day>27</day><month>8</month><year>2024</year></pub-date><volume>67</volume><issue seq="1434">Suppl 1</issue><issue-title content-type="special_issue">Abstracts of the 32nd European Congress of Psychiatry</issue-title><fpage>S702</fpage><lpage>S702</lpage><permissions><copyright-statement>&#x000a9; The Author(s) 2024</copyright-statement><copyright-year>2024</copyright-year><copyright-holder>The Author(s)</copyright-holder><license><ali:license_ref xmlns:ali="http://www.niso.org/schemas/ali/1.0/" specific-use="textmining" content-type="ccbylicense">https://creativecommons.org/licenses/by/4.0/</ali:license_ref><license-p>This is an Open Access article, distributed under the terms of the Creative Commons Attribution licence (<uri xlink:href="https://creativecommons.org/licenses/by/4.0/">https://creativecommons.org/licenses/by/4.0/</uri>), which permits unrestricted re-use, distribution, and reproduction in any medium, provided the original work is properly cited.</license-p></license></permissions><self-uri xlink:title="pdf" xlink:href="S0924933824014597a.pdf"/><abstract><sec id="sec7869"><title>Introduction</title><p>The U.S. Food &#x00026; Drug Administration (FDA) has cleared SNT (Stanford Neuromodulation Therapy) for treatment of major depressive disorder (MDD) in adults who have failed to achieve improvement from at least two prior trials of antidepressants.&#x000a0;SNT protocol requires both structural and functional connectivity MRIs which is limited by high cost and lack of availability, its use without neuronavigation is still considered an off label use and need more investigation.</p></sec><sec id="sec7870"><title>Objectives</title><p>1-To investigate efficacy of SNT like accelerated off-label protocol without Neuronavigation in treating patients with TRD and suicidality.</p><p>2-To investigate durabiliy ( up to one month ) of SNT like accelerated off-label protocol without Neuronavigation in treating patients with TRD and suicidality</p></sec><sec id="sec7871"><title>Methods</title><p>
Two cases diagnosed as treatment resistant unipolar depression with suicidal ideations received accelerated intermittent theta burst stimulation (a iTBS); with figure of eight coil administered to the left dorsolateral prefrontal cortex (DL-PFC) determined using Beam method. Stimulation was at 90% MT for 1800 pulses with an intersession interval of fifty minutes. Patients received ten sessions every day for five consecutive days for a total of fifty sessions (90,000 pulses). The following scales were applied at the baseline and at the end of each day of five treatment days:The Montgomery and Asberg Depression Rating Scale (MADRS) The Beck Depression Inventory, Columbia Suicide Severity Rating Scale (C-SSRS) and Young Mania Rating Scale (YMRS).</p></sec><sec id="sec7872"><title>Results</title><p>The two cases at the end of the fifth day were completely improved regarding both suicidal ideations and depression without emerging of hypomania. Follow up was done weekly for one month with durable results.</p></sec><sec id="sec7873"><title>Conclusions</title><p>SNT protocol without neuronavigation needs to be well investigated in suppressing both suicidality and depression in patients with TRD.</p></sec><sec id="sec7874"><title>Disclosure of Interest</title><p>None Declared</p></sec></abstract><counts><page-count count="1"/></counts></article-meta></front></article>